NCI Cancer Bulletin: Top 10 Feature Stories Since January

August 24, 2010 Dear NCI Cancer Bulletin Subscriber, The editors, writers, and technical staff of the NCI Cancer Bulletin would like to thank each of you for your continued interest in our newsletter. We will not publish an issue today due to our summer production break, but we will resume biweekly publication on September 7. In the meantime, we have compiled a list below of the 10 most popular feature-length stories published so far this year, according to reader page views: FDA Approves First Therapeutic Cancer Vaccine (May 4) Physicians Urged to Consider Active Surveillance in Prostate Cancer (Jan. 12) Experimental Drug Benefits Patients with Advanced Prostate Cancer (Mar. 9) Chemotherapy-induced Peripheral Neuropathy (Feb. 23) The Downside of Diagnostic Imaging (Jan. 26) Melanoma Drugs Have Unintended Effects in Some Tumors (Feb. 9) New Cancer Drugs Bring New Side Effects, and Nurses Respond (Jan. 12) Trials Point to Potential Advances in Lung Cancer Treatment (Jan. 26) Personalizing Biomarkers for Cancer (Feb. 23) I-SPY2: Breast Cancer Trial Aims to Speed Drugs to the Clinic (Mar. 23) We are especially proud of our ability to bring you stories like these through RSS and Twitter feeds, as well as to present our content via a variety of platforms like YouTube and Facebook. In addition, for those who may prefer to read selected articles in Spanish, we have a Spanish-language version of the newsletter. Thank you again for your interest and support. We hope you’ll continue to read each issue and encourage others to subscribe. Best regards, The NCI Cancer Bulletin Team

NCI Cancer Bulletin for August 10, 2010

August 10, 2010 • Volume 7 / Number 16 Read the NCI Cancer Bulletin The latest issue of the NCI Cancer Bulletin is now available at http://www.cancer.gov/ncicancerbulletin. Keep up to date on the latest research and advances in the prevention, treatment, and understanding of cancer. News Read This Issue Featured Article: Protein Helps Predict Cancer Therapy-induced Heart Damage »  Bone Drugs Do Not Appear to Increase Esophageal or Gastric Cancer Risk »  Immune Cells' Anticancer Abilities May Be Hampered by High Lipid Levels »  microRNA May Regulate Growth of Tumor Blood Vessels »  Many U.S. and Canadian Oncologists Unprepared to Use Cost-effectiveness Data in Practice »  In Depth Read This Issue A Cancer Treatment That Sticks Around »  NCI's Cancer Information Service: Providing Information and Assistance Nationwide  »  Featured Clinical Trial: Cediranib to Treat Alveolar Soft Part Sarcoma »  The Comprehensive Cancer Center of Wake Forest University »  Updates Read This Issue Legislative Update »  Cancer.gov Update »  Notes »